- Enables streamlined stability testing and release of higher quality AAV-based gene therapy products. - Provides much needed European capacity…
HITRUST e1 Certification validates Roji Health Intelligence is committed to foundational cybersecurity controls and information risk managementCHICAGO, June 10, 2025…
Dr. Jon Block to Lead Vivex’s Completion of its Ascend and Restore Randomized Clinical Trials for VIA Disc® NP, Vivex’s…
Join Us in San Francisco, October 27-28! REDWOOD CITY, Calif., June 9, 2025 /PRNewswire/ -- The Tianqiao and Chrissy Chen…
NSCEB is launching a 3-month tour of the booming U.S. biotechnology ecosystem RALEIGH, N.C., June 6, 2025 /PRNewswire/ -- Yesterday,…
– Company to showcase preclinical studies of ARV-393, an investigational oral PROTAC BCL6 degrader, as a single agent in models…
Parents pursuing IVF now have a new level of choice to empower their family planning NEW YORK, June 4, 2025…
Three out of four efzofitimod-treated diffuse SSc-ILD patients showed clinically important improvement based on the modified Rodnan Skin Score (mRSS)…
WALTHAM, Mass., June 04, 2025 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals, Inc. (Nasdaq: APLS) today announced that the company will present at…
SION-719 and SION-451 were generally well tolerated and achieved desired pharmacokinetic targets that reinforce their potential as either an add-on…